| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2007PNAS..104..293K |
| P356 | DOI | 10.1073/PNAS.0609885104 |
| P932 | PMC publication ID | 1765452 |
| P698 | PubMed publication ID | 17190797 |
| P5875 | ResearchGate publication ID | 6609381 |
| P50 | author | Louis H. Miller | Q1646045 |
| Rachel Schneerson | Q20738112 | ||
| David L. Narum | Q55174557 | ||
| Joseph Shiloach | Q89256757 | ||
| Joanna Kubler-Kielb | Q90684213 | ||
| P2093 | author name string | Yimin Wu | |
| John B Robbins | |||
| Chunyan Guo | |||
| Fathy Majadly | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230 | Q30042991 | ||
| Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugates | Q33251442 | ||
| Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoid | Q33607442 | ||
| Malaria transmission-blocking vaccines--how can their development be supported? | Q33853275 | ||
| Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. | Q34002415 | ||
| Transmission-blocking vaccines. | Q34680152 | ||
| Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates | Q34714055 | ||
| Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine | Q35171265 | ||
| OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks | Q35552349 | ||
| Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen | Q36228960 | ||
| Restricted or absent immune responses in human populations to plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies | Q36355913 | ||
| Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies | Q36361298 | ||
| Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate | Q36958120 | ||
| Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals | Q42006764 | ||
| The measurement of amino groups in proteins and peptides | Q42922891 | ||
| Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent | Q42935742 | ||
| A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains | Q43525538 | ||
| Minimal variation in a vaccine candidate from the sexual stage of plasmodium falciparum | Q44023350 | ||
| Properties of epitopes of pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of plasmodium falciparum | Q44143594 | ||
| The 230-kDa gamete surface protein of plasmodium falciparum is also a target for transmission-blocking antibodies | Q44146561 | ||
| Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria | Q44164504 | ||
| Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris | Q48019028 | ||
| Large scale recovery and purification of periplasmic recombinant protein from E. coli using expanded bed adsorption chromatography followed by new ion exchange media. | Q53984708 | ||
| Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak | Q57110756 | ||
| A simplified method for determination of peptide-protein molar ratios using amino acid analysis | Q67976503 | ||
| Gas chromatographic analysis of amino acids as the N-heptafluorobutyryl isobutyl esters | Q68962388 | ||
| Immunological activity of cytochrome c. 3. Enhancement of antibody detection and immune response initiation by cytochrome c polymers | Q70129693 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| antibody | Q79460 | ||
| P304 | page(s) | 293-298 | |
| P577 | publication date | 2006-12-26 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25. | |
| P478 | volume | 104 |
| Q28550575 | A Method for Producing Protein Nanoparticles with Applications in Vaccines |
| Q33524699 | A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates. |
| Q35887438 | A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses |
| Q35048518 | A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice |
| Q28740771 | A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity |
| Q36718066 | Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders |
| Q37587612 | Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate |
| Q51772228 | Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future. |
| Q37274832 | Approaches to malaria vaccine development using the retrospectroscope |
| Q37170062 | Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates |
| Q34523734 | Bacterial superglue enables easy development of efficient virus-like particle based vaccines |
| Q35925379 | Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates |
| Q34341570 | Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle |
| Q44144794 | Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward |
| Q93099494 | Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha |
| Q44140071 | Efficacy model for mosquito stage transmission blocking vaccines for malaria |
| Q37386668 | Enhanced antibody responses to Plasmodium falciparum Pfs28 induced in mice by conjugation to ExoProtein A of Pseudomonas aeruginosa with an improved procedure |
| Q36442817 | Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology |
| Q34177472 | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination |
| Q47829675 | Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. |
| Q41989340 | Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate |
| Q36062237 | Evolution of the Transmission-Blocking Vaccine Candidates Pvs28 and Pvs25 in Plasmodium vivax: Geographic Differentiation and Evidence of Positive Selection |
| Q40785963 | Fiber knob domain lacking the shaft sequence but fused to a coiled coil is a candidate subunit vaccine against egg-drop syndrome |
| Q34128872 | Flipping the paradigm on malaria transmission-blocking vaccines. |
| Q36941152 | Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons |
| Q33297012 | Human immunity and the design of multi-component, single target vaccines |
| Q28484081 | Immunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1 |
| Q33963746 | Malaria vaccine development and how external forces shape it: an overview |
| Q37018637 | Malaria vaccines and their potential role in the elimination of malaria |
| Q36079818 | Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles |
| Q33801989 | New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission |
| Q36396040 | Particle-based platforms for malaria vaccines |
| Q35947113 | Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines |
| Q34119427 | Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization |
| Q36236790 | Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles |
| Q37713285 | Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding |
| Q36394182 | Recent advances in recombinant protein-based malaria vaccines |
| Q35182086 | Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes |
| Q56342219 | Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults |
| Q41233891 | Salmonella flagellin is a potent carrier-adjuvant for peptide conjugate to induce peptide-specific antibody response in mice |
| Q36998403 | Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response. |
| Q33892507 | The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species |
| Q40979878 | Transmission blocking malaria vaccines: Assays and candidates in clinical development |
| Q37704246 | Transmission blocking vaccines to control insect-borne diseases: a review |
| Q36933780 | Vaccines against malaria - an update |
| Q39141585 | Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes |
Search more.